Jamilya Kaibullayeva|Aliya Ualiyeva|Ainash Oshibayeva|Anar Dushpanova|John K. Marshall
Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study
Kazakh Institute of Oncology and Radiology|Al-Farabi Kazakh National University|Al-Farabi Kazakh National University|Al-Farabi Kazakh National University|McMaster University
backgroundaims paucity published data epidemiology inflammatory bowel disease ibd central asia kazakhstan therefore aimed study ibd prevalence patient awareness among adults kazakhstan methods crosssectional study carried among subjects sexes aged 18 years older using ibd alert questionnaire calproquest single fecal calprotectin test endoscopy biopsy verify ibd january december 2017 across regions kazakhstan participants included study providing informed consentresults 115556 subjects 128 confirmed ibd cases 36 crohns disease cd 92 ulcerative colitis uc cases identified age sexadjusted ibd prevalence 1139 95 confidence interval ci 6901589 per 100000 population age sexadjusted prevalence uc 844 95 ci 4481239 cd 295 95 ci 82509 per 100000 populationconclusions first report prevalence ibd verified diagnosis central asia could used better plan allocate healthcare resources ibd management program